← All markets

Authority

Food and Drug Administration (FDA Philippines), Center for Cosmetics Regulation and Research

Main regulation

RA 9711 (2009); AO 2005-0025; FDA Circular 2023-001 (PIF) · Republic Act No. 9711 (FDA Act of 2009) amending RA 3720, with the ASEAN Cosmetic Directive adopted by DOH Administrative Order No. 2005-0025

In force

2008-01-01

Market entry

Pre-market Cosmetic Product Notification via the FDA eServices portal (with PIF upload) before distribution, valid 1–3 years and renewable.

Responsible person

A Philippine company holding an FDA License to Operate (LTO) as manufacturer, importer or distributor must file the notification and appear on the label.

Safety file

Product Information File per ACD Art. 8 under FDA Circular 2023-001, kept by the LTO holder for inspection.

Labeling

ACD Appendix I labelling in English or Filipino: product name and function, full ingredient list, country of manufacture, LTO holder name/address, contents, batch, manufacturing/expiry date and precautions, with claims following the ACD claims guidelines.

Animal testing

No ban and no requirement.

Ingredient lists

ACD Annexes II–VII as adopted through FDA circulars (latest FDA Circular 2026-0001; FDA Circular 2025-002 of 2025-03-18 adopted the 39th ACC changes such as the DEET ban).

Notes

ACD applied from 2008-01-01 while RA 9711 itself dates from 2009; notification validity (1–3 years) is from consultancy sources.

Look up this inventory here

东盟 · ASEAN Cosmetic Directive — Annexes

Official text

https://www.fda.gov.ph/fda-circular-no-2026-0001-consolidated-amendments-to-the-asean-cosmetic-directive-acd-as-adopted-during-the-40th-to-42nd-asean-cosmetic-committee-acc-meeting-and-their-related-meetings/

Source: 1234

Entering Philippines? Send the product type and we reply with the factory-side document list and lead time. Send an inquiry